Turn Bio’s $300M Deal to Unlock the Fountain of Youth
Turn Biotechnologies announced an exclusive global licensing agreement with HanAll Biopharma valued at over $300 million.
Read moreTurn Biotechnologies announced an exclusive global licensing agreement with HanAll Biopharma valued at over $300 million.
Read more© 2024 Lumida Wealth Management LLC is an SEC registered investment adviser. Disclaimer.
© 2024 Lumida Wealth Management LLC is an SEC registered investment adviser. Disclaimer.